Cofinimmo reports 1Q24 results in line with our expectations. We were however more negative on potential fair value corrections (-46m,-0.7% vs -99m exp). They were mainly driven by the office segment -1.3% versus -0.7% in HC. In FY24 it expects divestments to be almost net neutral. This was the case in 1Q24 with both 30m divestments and investments. There is another 31m assets held for sale (60/270m confirmed). To date asset sales are lagging a bit but markets are likely to pick up in 2H24. Div...
Umicore commented that market dynamics in 1Q were in line with its expectations and the company reiterated its FY24 adj EBITDA guidance range of € 900-950m which represents at midpoint a 5% drop y/y. We continue to believe Umicore is well placed to play an important role in the electrification of transportation as we believe that global OEMs are still determined to establish local supply chains in Europe and North America. HLM and solid-state technologies will in our opinion support the position...
We updated our X-Fab model after the 1Q24 results and we lowered our 2Q24 revenue forecast as X-Fab indicated this is expected to come in within a range of $ 200-210m with an EBITDA-margin in the range of 20-23%. Positive on the other hand was that FY24 guidance was reiterated with revenue in a range of $900-970m (KBCSe from $ 948m to $930.0m after this update) and an EBITDA margin in the range of 25-29% (KBCSe from 26.8%, to 26.7%). We lower our Target Price to € 10 (from € 11), in line with ...
1Q24 results were slightly better than expected with Core adj EBITDA +0.7% organically vs -2% expected. FY24 guidance of at least 15% adj. EBITDA growth for the Core operations was reiterated. PLA sales have turned upwards and a € 20m share buyback and € 0.1 special dividend has been announced following the sale of Emulsifiers. Although the recent track record has been more volatile than expected, the strategic choices made recently (sticking to PLA, a disciplined investment approach on ao Algae...
We update our model after the 1Q24 results and take into account the exit from the Dutch market, JV closing and non-strategic asset sales announced in 1Q24. We believe the stock price did not react enough to the positive catalyst of the Dutch sales and JV closing at 15.13% IRR. Hence, we repeat our BUY recommendation and EUR 13.0 TP. Standing asset valuations increased with 1.3% in 1Q24 signalling the revival of retail real estate. This is also reflected in the record high occupancy rate at 99....
Onward reported its FY23 results, and confirmed its FY24 outlook and key milestones. 2024 is set to become the year of its first launch, with ARCEX approval expected 2H24. Meanwhile, the pivotal trial in blood pressure control with ARCIM remains planned to start 2H24. YE23 cash landed at € 29.8m and was complemented with a € 20m equity raise to deliver cash runway into mid-2025. We reiterate our Buy rating and € 9.3 TP.
Heineken reported better than expected 1Q organic total volume trends (+4.3%). Even when stripping out easy comparatives in Nigeria & Vietnam, 1Q results show a combination of both underlying volume growth and further price/mix improvement which is in our opinion a testimony to the resilience of both Heineken and the broader beer category. FY24 guidance calling for a low to high single digit organic operating profit (beia) growth was maintained, but the CFO's comments in the conference call that...
1Q24 below our and CSS forecasts and we and CSS will have to lower our 2Q24 forecast ($ 231.3m and $ 227.9m respectively) as X-Fab indicated this is expected to come in within a range of $ 200-210m with an EBITDA-margin in the range of 20-23% (KBCSe 26.1%, CSS 26.2%). Positive on the other hand is that FY24 guidance was reiterated.
Despite the weaker 1Q24 film offering and the lower visitor numbers associated with this (7.3m in 1Q24 -perfect in line with our estimates- versus 8.1m in 1Q23), we applauded that Kinepolis indicated they generated strong results per visitor and 1Q24 FCF was even stronger than in 1Q23. Kinepolis highlighted that this ‘Sales/visitor' remained high, thanks to strong demand for premium products, but was occasionally impacted by the product mix in 1Q. We maintain our € 53 Target Price and Buy.
In this note we make a small adjustment to our forecast, give a valuation overview and change our valuation method. We still see reasons to remain cautious as inventories remain elevated, while the divergence between WFE revenue growth and Semi manufacturers CapEx growth continues to diverge. Furthermore, we provide an extensive multiple overview. Finally, we adjust our valuation method. Our current target price is for 50% based on DCF valuation, 30% based on peer multiples and 20% based on 2025...
Heineken reported better than expected organic volume and revenue growth in 1Q (c. 2pp above CSS) and reiterated its FY24 guidance calling for a low to high single digit organic operating profit (beia) growth, with our and consensus forecasts at respectively +5% and +7%. We expect inflation for brewers like Heineken to gradually ease going forward whilst we believe the beer category has historically demonstrated solid pricing discipline. Together with further savings potential, we expect Heineke...
Since the start of March 2024, Syensqo has risen by 8.0% while Solvay has rallied 28.0%. However, in stark contrast to its underlying investments, Solvac has declined by -2.8% during the same time period. As a result, we estimate Solvac's discount to have widened to 38.4% which is much higher that the 2yr and 5yr average discount(s) of 24.3% and 20.7% respectively. While lower volumes in the name could be one reason, we also believe that the market has not fully re-calibrated its view of Solvac ...
Despite the turmoil in the automotive semiconductor market recently, Melexis highlighted that the inventory corrections in some product lines throughout the past few quarters are now gone. Melexis mentioned even an “ever-increasing demand for automotive semiconductors addressing electrification and the increasing need for comfort and safety applications”. We reiterate our Accumulate rating and maintain our € 110 TP as Melexis highlighted that the cost optimization measures taken in 4Q23 will ens...
We updated our model after 1Q24 orders and sales declined more than we and CSS expected compared to a strong 1Q23, reflecting destocking by Barco's customers, mainly in Meeting Experience and Healthcare, and weaker demand in Entertainment markets. We have incorporated into our model that Barco expects FY24 topline to be in line with FY23, with y/y growth resuming in 2H24 (recall that previously it was "with a gradual y/y increase from 2Q"). For FY25, Barco expects top-line growth on a full-year ...
Below are the highlights from the conference call. We remind that 1Q adj. EBITDA jumped by 19% to 363m, which was about 4% better than our and consensus forecasts. Unsurprisingly, Akzo reiterated its FY24 guidance of €1.5-1.65bn adj. EBITDA, which represents c.10% growth at midpoint. Mid term guidance of at least 16% adjusted EBITDA margin was also reiterated and represents a 260bps increase from 2023A with our and consensus a bit below (at respectively 15.5% and 15.7%). We acknowledge the impro...
Titan Cement announced that the US Department of Energy has selected Titan America's Roanoke cement plant in Virginia to support the deployment of a first-of-a-kind calcined clay production line by awarding up to $61.7m. The implementation of the technology will substantially reduce carbon emissions and become a model for building more sustainable infrastructure across the Group. The $61.7m grant will be part of the $6.3bn Industrial Demonstrations Program in the USA, which is managed by DOE's O...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.